{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:53:21Z","timestamp":1790175201367,"version":"4.1.0"},"reference-count":193,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T00:00:00Z","timestamp":1706659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>To achieve the World Health Organization\u2019s global Sustainable Development Goals, increased production of high-quality protein for human consumption is required while minimizing, ideally reducing, environmental impacts. One way to achieve these goals is to address losses within current livestock production systems. Infectious diseases are key limiters of edible protein production, affecting both quantity and quality. In addition, some of these diseases are zoonotic threats and potential contributors to the emergence of antimicrobial resistance. Vaccination has proven to be highly successful in controlling and even eliminating several livestock diseases of economic importance. However, many livestock diseases, both existing and emerging, have proven to be recalcitrant targets for conventional vaccination technologies. The threat posed by the COVID-19 pandemic resulted in unprecedented global investment in vaccine technologies to accelerate the development of safe and efficacious vaccines. While several vaccination platforms emerged as front runners to meet this challenge, the clear winner is mRNA-based vaccination. The challenge now is for livestock industries and relevant stakeholders to harness these rapid advances in vaccination to address key diseases affecting livestock production. This review examines the key features of mRNA vaccines, as this technology has the potential to control infectious diseases of importance to livestock production that have proven otherwise difficult to control using conventional approaches. This review focuses on the challenging diseases of ruminants due to their importance in global protein production. Overall, the current literature suggests that, while mRNA vaccines have the potential to address challenges in veterinary medicine, further developments are likely to be required for this promise to be realized for ruminant and other livestock species.<\/jats:p>","DOI":"10.3390\/vaccines12020152","type":"journal-article","created":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T08:44:06Z","timestamp":1706690646000},"page":"152","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Can the Revolution in mRNA-Based Vaccine Technologies Solve the Intractable Health Issues of Current Ruminant Production Systems?"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4573-7906","authenticated-orcid":false,"given":"Timothy J.","family":"Mahony","sequence":"first","affiliation":[{"name":"Centre for Animal Science, Queensland Alliance for Agriculture and Food Innovation, The University of Queensland, Brisbane, QLD 4072, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9312-742X","authenticated-orcid":false,"given":"Tatiana E.","family":"Briody","sequence":"additional","affiliation":[{"name":"Centre for Animal Science, Queensland Alliance for Agriculture and Food Innovation, The University of Queensland, Brisbane, QLD 4072, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0780-0399","authenticated-orcid":false,"given":"Sheila C.","family":"Ommeh","sequence":"additional","affiliation":[{"name":"Centre for Animal Science, Queensland Alliance for Agriculture and Food Innovation, The University of Queensland, Brisbane, QLD 4072, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/d41586-021-02522-6","article-title":"How far will global population rise? Researchers can\u2019t agree","volume":"597","author":"Adam","year":"2021","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"s188","DOI":"10.1017\/S1751731118002215","article-title":"Review: Domestic herbivores and food security: Current contribution, trends and challenges for a sustainable development","volume":"12","author":"Mottet","year":"2018","journal-title":"Animal"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"111941","DOI":"10.1016\/j.nut.2022.111941","article-title":"Changes in energy, macronutrient, and food consumption in 47 countries over the last 70 years (1950\u20132019): A systematic review and meta-analysis","volume":"108","author":"Sikorski","year":"2023","journal-title":"Nutrition"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.tree.2013.12.001","article-title":"Agricultural expansion and its impacts on tropical nature","volume":"29","author":"Laurance","year":"2014","journal-title":"Trends Ecol. Evol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.20506\/rst.36.2.2663","article-title":"Animal pathogens and their impact on animal health, the economy, food security, food safety and public health","volume":"36","author":"McElwain","year":"2017","journal-title":"Rev. Sci. Tech."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/jwas.12936","article-title":"The many challenges of disease management in aquaculture","volume":"53","author":"Cain","year":"2022","journal-title":"J. World Aquac. Soc."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.provac.2011.10.009","article-title":"Veterinary vaccines and their importance to animal health and public health","volume":"5","author":"Roth","year":"2011","journal-title":"Procedia Vaccinol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Vidovic, N., and Vidovic, S. (2020). Antimicrobial resistance and food animals: Influence of livestock environment on the emergence and dissemination of antimicrobial resistance. Antibiotics, 9.","DOI":"10.3390\/antibiotics9020052"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Craig, J., Sadoff, R., Bennett, S., Bahati, F., and Beauvais, W. (2023). Behavior-change interventions to improve antimicrobial stewardship in human health, animal health, and livestock agriculture: A systematic review. PLoS Glob. Public Health, 3.","DOI":"10.1101\/2023.01.04.23284191"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1017\/S1751731117002592","article-title":"Review: Optimizing ruminant conversion of feed protein to human food protein","volume":"12","author":"Broderick","year":"2018","journal-title":"Animal"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Li, Y.D., Chi, W.Y., Su, J.H., Ferrall, L., Hung, C.F., and Wu, T.C. (2020). Coronavirus vaccine development: From sars and mers to COVID-19. J. Biomed. Sci., 27.","DOI":"10.1186\/s12929-020-00695-2"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.biori.2017.10.001","article-title":"The development of veterinary vaccines: A review of traditional methods and modern biotechnology approaches","volume":"1","author":"Jorge","year":"2017","journal-title":"Biotechnol. Res. Innov."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1128\/CMR.00005-07","article-title":"Current status of veterinary vaccines","volume":"20","author":"Meeusen","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"697194","DOI":"10.3389\/fvets.2021.697194","article-title":"Recent development of ruminant vaccine against viral diseases","volume":"8","author":"Choudhury","year":"2021","journal-title":"Front. Vet. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force Members (2021). Operation warp speed: Implications for global vaccine security. Lancet Glob. Health, 9, e1017\u2013e1021.","DOI":"10.1016\/S2214-109X(21)00140-6"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1073\/pnas.86.16.6077","article-title":"Cationic liposome-mediated RNA transfection","volume":"86","author":"Malone","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1690918","article-title":"Direct gene transfer into mouse muscle in vivo","volume":"247","author":"Wolff","year":"1990","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/eji.1830230749","article-title":"Induction of virus-specific cytotoxic t lymphocytes in vivo by liposome-entrapped mrna","volume":"23","author":"Martinon","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"ref_19","first-page":"1397","article-title":"Characterization of a messenger RNA polynucleotide vaccine vector","volume":"55","author":"Conry","year":"1995","journal-title":"Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/CJI.0b013e31815ce501","article-title":"Results of the first phase I\/II clinical vaccination trial with direct injection of mRNA","volume":"31","author":"Weide","year":"2008","journal-title":"J. Immunother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"100766","DOI":"10.1016\/j.nantod.2019.100766","article-title":"Three decades of messenger RNA vaccine development","volume":"28","author":"Verbeke","year":"2019","journal-title":"Nanotoday"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines\u2014A new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Borah, P., Deb, P.K., Al-Shar\u2019i, N.A., Dahabiyeh, L.A., Venugopala, K.N., Singh, V., Shinu, P., Hussain, S., Deka, S., and Chandrasekaran, B. (2021). Perspectives on RNA vaccine candidates for COVID-19. Front. Mol. Biosci., 8.","DOI":"10.3389\/fmolb.2021.635245"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Donadeu, M., Nwankpa, N., Abela-Ridder, B., and Dungu, B. (2019). Strategies to increase adoption of animal vaccines by smallholder farmers with focus on neglected diseases and marginalized populations. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0006989"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41434-020-00204-y","article-title":"Self-amplifying RNA vaccines for infectious diseases","volume":"28","author":"Bloom","year":"2021","journal-title":"Gene Ther."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Kis, Z., Kontoravdi, C., Shattock, R., and Shah, N. (2020). Resources, production scales and time required for producing rna vaccines for the global pandemic demand. Vaccines, 9.","DOI":"10.3390\/vaccines9010003"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.vaccine.2018.11.050","article-title":"A cost analysis of producing vaccines in developing countries","volume":"37","author":"Munira","year":"2019","journal-title":"Vaccine"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/01410768211053006","article-title":"The costs of coronavirus vaccines and their pricing","volume":"114","author":"Light","year":"2021","journal-title":"J. R. Soc. Med."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Ferreira, R.G., Gordon, N.F., Stock, R., and Petrides, D. (2021). Adenoviral vector COVID-19 vaccines: Process and cost analysis. Processes, 9.","DOI":"10.3390\/pr9081430"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13273-021-00171-4","article-title":"Modifications of mrna vaccine structural elements for improving mrna stability and translation efficiency","volume":"18","author":"Kim","year":"2022","journal-title":"Mol. Cell. Toxicol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Wang, Y.S., Kumari, M., Chen, G.H., Hong, M.H., Yuan, J.P., Tsai, J.L., and Wu, H.C. (2023). Mrna-based vaccines and therapeutics: An in-depth survey of current and upcoming clinical applications. J. Biomed. Sci., 30.","DOI":"10.1186\/s12929-023-00977-5"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"7511","DOI":"10.1093\/nar\/gkw551","article-title":"mRNA capping: Biological functions and applications","volume":"44","author":"Ramanathan","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/imr.13020","article-title":"How RNA modifications regulate the antiviral response","volume":"304","author":"Thompson","year":"2021","journal-title":"Immunol. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Brito Querido, J., Diaz-Lopez, I., and Ramakrishnan, V. (2023). The molecular basis of translation initiation and its regulation in eukaryotes. Nat. Rev. Mol. Cell Biol., 1\u201319.","DOI":"10.1038\/s41580-023-00624-9"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","article-title":"Structural and functional properties of SARS-CoV-2 spike protein: Potential antivirus drug development for COVID-19","volume":"41","author":"Huang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s11033-021-06749-4","article-title":"Codon usage bias","volume":"49","author":"Parvathy","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Fox, D.M., Branson, K.M., and Walker, R.C. (2021). mRNA codon optimization with quantum computers. PLoS ONE, 16.","DOI":"10.1101\/2021.02.19.431999"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1074\/jbc.REV118.002814","article-title":"The stop-and-go traffic regulating protein biogenesis: How translation kinetics controls proteostasis","volume":"294","author":"Stein","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12964-020-00642-6","article-title":"A code within the genetic code: Codon usage regulates co-translational protein folding","volume":"18","author":"Liu","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"E6117","DOI":"10.1073\/pnas.1606724113","article-title":"Codon usage is an important determinant of gene expression levels largely through its effects on transcription","volume":"113","author":"Zhou","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of microRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"Hayder","year":"2018","journal-title":"Front. Endocrinol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41580-021-00417-y","article-title":"Roles of mRNA poly(A) tails in regulation of eukaryotic gene expression","volume":"23","author":"Passmore","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Khan, A.S., Mallet, L., Blumel, J., Cassart, J.P., Knezevic, I., Ng, S.H.S., Wall, M., Jakava-Viljanen, M., Logvinoff, C., and Goios, A. (2023). Report of the third conference on next-generation sequencing for adventitious virus detection in biologics for humans and animals. Biologicals, 83.","DOI":"10.1016\/j.biologicals.2023.101696"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Liang, Q., Tu, B., and Cui, L. (2024). Recombinant T7 RNA polymerase production using clearcoli BL21(DE3) and animal-free media for in vitro transcription. Appl. Microbiol. Biotechnol., 108.","DOI":"10.1007\/s00253-023-12939-w"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by toll-like receptors: The impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Kariko","year":"2005","journal-title":"Immunity"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"Kariko","year":"2008","journal-title":"Mol. Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"5884","DOI":"10.1093\/nar\/gkq347","article-title":"Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation","volume":"38","author":"Anderson","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"9329","DOI":"10.1093\/nar\/gkr586","article-title":"Nucleoside modifications in RNA limit activation of 2\u2019-5\u2019-oligoadenylate synthetase and increase resistance to cleavage by RNase L","volume":"39","author":"Anderson","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.copbio.2021.09.016","article-title":"Principles for designing an optimal mRNA lipid nanoparticle vaccine","volume":"73","author":"Kon","year":"2022","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","article-title":"Innate immune mechanisms of mRNA vaccines","volume":"55","author":"Verbeke","year":"2022","journal-title":"Immunity"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.3762\/bjoc.13.274","article-title":"Synthetic mRNA capping","volume":"13","author":"Muttach","year":"2017","journal-title":"Beilstein. J. Org. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(17)31665-3","article-title":"Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: An open-label, non-randomised, prospective, first-in-human phase 1 clinical trial","volume":"390","author":"Alberer","year":"2017","journal-title":"Lancet"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40290-021-00417-5","article-title":"Delivery strategies for mRNA vaccines","volume":"36","author":"Ramachandran","year":"2022","journal-title":"Pharm. Med."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Wei, J., and Hui, A.M. (2022). The delivery of mRNA vaccines for therapeutics. Life, 12.","DOI":"10.3390\/life12081254"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ymthe.2019.02.012","article-title":"Delivering the messenger: Advances in technologies for therapeutic mRNA delivery","volume":"27","author":"Kowalski","year":"2019","journal-title":"Mol. Ther."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Balhorn, R. (2007). The protamine family of sperm nuclear proteins. Genome Biol., 8.","DOI":"10.1186\/gb-2007-8-9-227"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CJI.0b013e3181f7dbe8","article-title":"Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity","volume":"34","author":"Duchardt","year":"2011","journal-title":"J. Immunother."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/eji.200425656","article-title":"Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNA","volume":"35","author":"Scheel","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jconrel.2016.02.043","article-title":"Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra- and paracellular pathways","volume":"228","author":"Li","year":"2016","journal-title":"J. Control. Release"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Li, D., Song, H., Li, J., Liu, X., Gao, X., Wu, T., Zhang, Z., and Li, Y. (2022). Expression and evaluation of a novel PPRV nanoparticle antigen based on ferritin self-assembling technology. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14091902"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1021\/acs.nanolett.7b02664","article-title":"Boosting intracellular delivery of lipid nanoparticle-encapsulated mRNA","volume":"17","author":"Patel","year":"2017","journal-title":"Nano Lett."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Paramasivam, P., Franke, C., Stoter, M., Hoijer, A., Bartesaghi, S., Sabirsh, A., Lindfors, L., Arteta, M.Y., Dahlen, A., and Bak, A. (2022). Endosomal escape of delivered mRNA from endosomal recycling tubules visualized at the nanoscale. J. Cell Biol., 221.","DOI":"10.1083\/jcb.202110137"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cvfa.2019.07.003","article-title":"Vaccination management of beef cattle: Delayed vaccination and endotoxin stacking","volume":"35","author":"Richeson","year":"2019","journal-title":"Vet. Clin. N. Am. Food Anim. Pract."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cvfa.2020.03.006","article-title":"Bovine respiratory disease vaccination against viral pathogens: Modified-live versus inactivated antigen vaccines, intranasal versus parenteral, what is the evidence?","volume":"36","author":"Chamorro","year":"2020","journal-title":"Vet. Clin. N. Am. Food Anim. Pract."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Roeder, P., Mariner, J., and Kock, R. (2013). Rinderpest: The veterinary perspective on eradication. Philos. Trans. R. Soc. Lond. B Biol. Sci., 368.","DOI":"10.1098\/rstb.2012.0139"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"104117","DOI":"10.1016\/j.lpm.2022.104117","article-title":"Life and death of smallpox","volume":"51","author":"Berche","year":"2022","journal-title":"Presse Med."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Zhou, L., Ge, X., and Yang, H. (2021). Porcine reproductive and respiratory syndrome modified live virus vaccine: A \u201cleaky\u201d vaccine with debatable efficacy and safety. Vaccines, 9.","DOI":"10.3390\/vaccines9040362"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1294929","DOI":"10.3389\/fimmu.2023.1294929","article-title":"Straight to the point: Targeted mRNA-delivery to immune cells for improved vaccine design","volume":"14","author":"Clemente","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"906457","DOI":"10.3389\/fimmu.2022.906457","article-title":"Comparison of immune responses elicited by SARS-CoV-2 mRNA and recombinant protein vaccine candidates","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"100793","DOI":"10.1016\/j.xcrm.2022.100793","article-title":"A comparative characterization of SARS-CoV-2-specific t cells induced by mRNA or inactive virus COVID-19 vaccines","volume":"3","author":"Lim","year":"2022","journal-title":"Cell Rep. Med."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Azzi, L., Dalla Gasperina, D., Veronesi, G., Shallak, M., Ietto, G., Iovino, D., Baj, A., Gianfagna, F., Maurino, V., and Focosi, D. (2022). Mucosal immune response in BNT162B2 COVID-19 vaccine recipients. EBioMedicine, 75.","DOI":"10.1016\/j.ebiom.2021.103788"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Nickel, O., Rockstroh, A., Wolf, J., Landgraf, S., Kalbitz, S., Kellner, N., Borte, M., Pietsch, C., Fertey, J., and Lubbert, C. (2022). Evaluation of the systemic and mucosal immune response induced by COVID-19 and the BNT162B2 mRNA vaccine for SARS-CoV-2. PLoS ONE, 17.","DOI":"10.1101\/2022.01.29.22270066"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/s41385-018-0006-7","article-title":"Oral cholera vaccination promotes homing of iga(+) memory b cells to the large intestine and the respiratory tract","volume":"11","author":"Timmerman","year":"2018","journal-title":"Mucosal Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"8598","DOI":"10.1016\/j.vaccine.2007.09.073","article-title":"Sublingual immunization induces broad-based systemic and mucosal immune responses in mice","volume":"25","author":"Cuburu","year":"2007","journal-title":"Vaccine"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jconrel.2020.12.029","article-title":"Mucoadhesive wafers composed of binary polymer blends for sublingual delivery and preservation of protein vaccines","volume":"330","author":"Hanson","year":"2021","journal-title":"J. Control. Release"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Martinez, D.A., Chamorro, M.F., Passler, T., Huber, L., Walz, P.H., Thoresen, M., Raithel, G., Silvis, S., Stockler, R., and Woolums, A.R. (2022). Local and systemic antibody responses in beef calves vaccinated with a modified-live virus bovine respiratory syncytial virus (BRSV) vaccine at birth following BRSV infection. Vet. Sci., 10.","DOI":"10.3390\/vetsci10010020"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"eaav5701","DOI":"10.1126\/scitranslmed.aav5701","article-title":"Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice","volume":"12","author":"Willis","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"24075","DOI":"10.1073\/pnas.1908052116","article-title":"mRNA structure regulates protein expression through changes in functional half-life","volume":"116","author":"Mauger","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.ygeno.2018.08.009","article-title":"The optimization of mRNA expression level by its intrinsic properties-insights from codon usage pattern and structural stability of mRNA","volume":"111","author":"Victor","year":"2019","journal-title":"Genomics"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41586-023-06127-z","article-title":"Algorithm for optimized mRNA design improves stability and immunogenicity","volume":"621","author":"Zhang","year":"2023","journal-title":"Nature"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/S2542-5196(17)30011-6","article-title":"From big to small: The significance of smallholder farms in the global food system","volume":"1","author":"Fanzo","year":"2017","journal-title":"Lancet Planet. Health"},{"key":"ref_83","first-page":"37","article-title":"Evaluation of bovine respiratory syncytial virus (BRSV) and bovine herpesvirus (BHV) specific antibody responses between heterologous and homologous prime-boost vaccinated western Canadian beef calves","volume":"62","author":"Erickson","year":"2021","journal-title":"Can. Vet. J."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1099\/vir.0.83251-0","article-title":"DNA prime protein boost strategies protect cattle from bovine viral diarrhea virus type 2 challenge","volume":"89","author":"Liang","year":"2008","journal-title":"J. Gen. Virol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1016\/j.vaccine.2016.05.053","article-title":"Evaluation of different heterologous prime-boost immunization strategies against Babesia bovis using viral vectored and protein-adjuvant vaccines based on a chimeric multi-antigen","volume":"34","author":"Ortiz","year":"2016","journal-title":"Vaccine"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41541-023-00684-0","article-title":"Analyzing immune responses to varied mRNA and protein vaccine sequences","volume":"8","author":"Park","year":"2023","journal-title":"NPJ Vaccines"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.livsci.2017.08.011","article-title":"Immune response of mature cows subjected to annual booster vaccination against neonatal calf diarrhoea with two different commercial vaccines: A non-inferiority study","volume":"204","author":"Durel","year":"2017","journal-title":"Livest. Sci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.omtn.2022.09.017","article-title":"Design and lyophilization of lipid nanoparticles for mRNA vaccine and its robust immune response in mice and nonhuman primates","volume":"30","author":"Suzuki","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e2309472120","DOI":"10.1073\/pnas.2309472120","article-title":"Combinatorial design of ionizable lipid nanoparticles for muscle-selective mRNA delivery with minimized off-target effects","volume":"120","author":"Chen","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Boley, P.A., Lee, C.M., Schrock, J., Yadav, K.K., Patil, V., Suresh, R., Lu, S., Feng, M.M., Hanson, J., and Channappanavar, R. (2023). Enhanced mucosal immune responses and reduced viral load in the respiratory tract of ferrets to intranasal lipid nanoparticle-based SARS-COV-2 proteins and mRNA vaccines. J. Nanobiotechnol., 21.","DOI":"10.1186\/s12951-023-01816-3"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41586-023-06800-3","article-title":"N(1)-methylpseudouridylation of mRNA causes +1 ribosomal frameshifting","volume":"625","author":"Mulroney","year":"2023","journal-title":"Nature"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1038\/s41467-020-16961-8","article-title":"High-throughput interrogation of programmed ribosomal frameshifting in human cells","volume":"11","author":"Mikl","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1128\/JVI.76.12.6054-6061.2002","article-title":"The genomes of sheeppox and goatpox viruses","volume":"76","author":"Tulman","year":"2002","journal-title":"J. Virol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.cell.2019.11.023","article-title":"Structural basis of poxvirus transcription: Transcribing and capping vaccinia complexes","volume":"179","author":"Hillen","year":"2019","journal-title":"Cell"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.tibs.2022.04.010","article-title":"Cytoplasmic gene expression: Lessons from poxviruses","volume":"47","author":"Grimm","year":"2022","journal-title":"Trends Biochem. Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1017\/S0950268800052067","article-title":"An investigation of possible routes of transmission of lumpy skin disease virus (neethling)","volume":"114","author":"Carn","year":"1995","journal-title":"Epidemiol. Infect."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"7436","DOI":"10.1038\/s41598-020-64029-w","article-title":"Non-vector-borne transmission of lumpy skin disease virus","volume":"10","author":"Aleksandr","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0007-1935(91)90019-J","article-title":"Lumpy skin disease, an African capripox virus disease of cattle","volume":"147","author":"Davies","year":"1991","journal-title":"Br. Vet. J."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Morgenstern, M., and Klement, E. (2020). The effect of vaccination with live attenuated neethling lumpy skin disease vaccine on milk production and mortality-an analysis of 77 dairy farms in Israel. Vaccines, 8.","DOI":"10.3390\/vaccines8020324"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"104595","DOI":"10.1016\/j.prevetmed.2018.12.001","article-title":"Neethling vaccine proved highly effective in controlling lumpy skin disease epidemics in the Balkans","volume":"181","author":"Klement","year":"2020","journal-title":"Prev. Vet. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2190647","DOI":"10.1080\/21505594.2023.2190647","article-title":"Evaluation of the safety, immunogenicity and efficacy of a new live-attenuated lumpy skin disease vaccine in India","volume":"14","author":"Kumar","year":"2023","journal-title":"Virulence"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"100209","DOI":"10.1016\/j.jvacx.2022.100209","article-title":"Improved safety profile of inactivated neethling strain of the lumpy skin disease vaccine","volume":"12","author":"Matsiela","year":"2022","journal-title":"Vaccine X"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Tuppurainen, E.S.M., Babiuk, S., and Klement, E. (2018). Lumpy Skin Disease, Springer.","DOI":"10.1007\/978-3-319-92411-3"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"19411","DOI":"10.1038\/s41598-022-23272-z","article-title":"Design of a multi-epitope protein as a subunit vaccine against lumpy skin disease using an immunoinformatics approach","volume":"12","author":"Kar","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Chervyakova, O., Issabek, A., Sultankulova, K., Bopi, A., Kozhabergenov, N., Omarova, Z., Tulendibayev, A., Aubakir, N., and Orynbayev, M. (2022). Lumpy skin disease virus with four knocked out genes was attenuated in vivo and protects cattle from infection. Vaccines, 10.","DOI":"10.3390\/vaccines10101705"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1099\/vir.0.81969-0","article-title":"Intraspecific bovine herpesvirus 1 recombinants carrying glycoprotein E deletion as a vaccine marker are virulent in cattle","volume":"87","author":"Muylkens","year":"2006","journal-title":"J. Gen. Virol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"4518","DOI":"10.1016\/j.vaccine.2019.06.059","article-title":"Isolation of a naturally occurring vaccine\/wild-type recombinant bovine herpesvirus type 1 (BoHV-1) from an aborted bovine fetus","volume":"37","author":"Fulton","year":"2019","journal-title":"Vaccine"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1038\/s41598-017-02460-2","article-title":"Systematic comparison of 2a peptides for cloning multi-genes in a polycistronic vector","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Wolff, J., Beer, M., and Hoffmann, B. (2023). Cross-protection of an inactivated and a live-attenuated lumpy skin disease virus vaccine against sheeppox virus infections in sheep. Vaccines, 11.","DOI":"10.3390\/vaccines11040763"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Shchelkunova, G.A., and Shchelkunov, S.N. (2022). Smallpox, monkeypox and other human orthopoxvirus infections. Viruses, 15.","DOI":"10.3390\/v15010103"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"33","DOI":"10.32607\/actanaturae.10935","article-title":"Genes that control vaccinia virus immunogenicity","volume":"12","author":"Shchelkunov","year":"2020","journal-title":"Acta Nat."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nmeth734","article-title":"Engineering of a vaccinia virus bacterial artificial chromosome in Escherichia coli by bacteriophage lambda-based recombination","volume":"2","author":"Domi","year":"2005","journal-title":"Nat. Methods"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1297-9716-42-3","article-title":"Recovery of infectious virus from full-length cowpox virus (CPXV) DNA cloned as a bacterial artificial chromosome (BAC)","volume":"42","author":"Roth","year":"2011","journal-title":"Vet. Res."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Noyce, R.S., Lederman, S., and Evans, D.H. (2018). Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0188453"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"5176","DOI":"10.1128\/JVI.00339-15","article-title":"Efficiently editing the vaccinia virus genome by using the CRISPR-Cas9 system","volume":"89","author":"Yuan","year":"2015","journal-title":"J. Virol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1099\/vir.0.2008\/002501-0","article-title":"The essential and non-essential genes of bovine herpesvirus 1","volume":"89","author":"Robinson","year":"2008","journal-title":"J. Gen. Virol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41392-023-01432-5","article-title":"Monkeypox virus quadrivalent mRNA vaccine induces immune response and protects against vaccinia virus","volume":"8","author":"Sang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2204151","DOI":"10.1080\/22221751.2023.2204151","article-title":"Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge","volume":"12","author":"Zeng","year":"2023","journal-title":"Emerg. Microbes Infect."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1128\/JVI.02095-06","article-title":"Complete genome analysis of 33 ecologically and biologically diverse rift valley fever virus strains reveals widespread virus movement and low genetic diversity due to recent common ancestry","volume":"81","author":"Bird","year":"2007","journal-title":"J. Virol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2478\/jvetres-2021-0009","article-title":"Rift valley fever\u2014A growing threat to humans and animals","volume":"65","author":"Kwasnik","year":"2021","journal-title":"J. Vet. Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1099\/0022-1317-75-6-1345","article-title":"Rift valley fever virus l segment: Correction of the sequence and possible functional role of newly identified regions conserved in RNA-dependent polymerases","volume":"75","author":"Muller","year":"1994","journal-title":"J. Gen. Virol."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Kitandwe, P.K., McKay, P.F., Kaleebu, P., and Shattock, R.J. (2022). An overview of rift valley fever vaccine development strategies. Vaccines, 10.","DOI":"10.3390\/vaccines10111794"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.antiviral.2012.06.001","article-title":"Molecular biology and genetic diversity of rift valley fever virus","volume":"95","author":"Ikegami","year":"2012","journal-title":"Antivir. Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1099\/0022-1317-66-10-2271","article-title":"Mutagen-directed attenuation of rift valley fever virus as a method for vaccine development","volume":"66","author":"Caplen","year":"1985","journal-title":"J. Gen. Virol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/14760584.2017.1321482","article-title":"Rift valley fever vaccines: An overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate","volume":"16","author":"Ikegami","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.1995.53.405","article-title":"Characterization of clone 13, a naturally attenuated avirulent isolate of rift valley fever virus, which is altered in the small segment","volume":"53","author":"Muller","year":"1995","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1016\/j.vaccine.2010.04.085","article-title":"Evaluation of the efficacy and safety of the rift valley fever clone 13 vaccine in sheep","volume":"28","author":"Dungu","year":"2010","journal-title":"Vaccine"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1016\/j.vaccine.2011.05.055","article-title":"Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves","volume":"29","author":"Engelbrecht","year":"2011","journal-title":"Vaccine"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41541-020-00271-7","article-title":"A single vaccination with four-segmented rift valley fever virus prevents vertical transmission of the wild-type virus in pregnant ewes","volume":"6","author":"Oymans","year":"2021","journal-title":"NPJ Vaccines"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Ly, H.J., Lokugamage, N., Nishiyama, S., and Ikegami, T. (2017). Risk analysis of inter-species reassortment through a rift valley fever phlebovirus mp-12 vaccine strain. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0185194"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"6634","DOI":"10.1016\/j.vaccine.2017.10.036","article-title":"Attenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain","volume":"35","author":"Ly","year":"2017","journal-title":"Vaccine"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S1473-3099(23)00068-3","article-title":"Safety and immunogenicity of a chadox1 vaccine against Rift Valley fever in UK adults: An open-label, non-randomised, first-in-human phase 1 clinical trial","volume":"23","author":"Jenkin","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Bhardwaj, N., Heise, M.T., and Ross, T.M. (2010). Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus. PLoS Negl. Trop. Dis., 4.","DOI":"10.1371\/journal.pntd.0000725"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1016\/j.vaccine.2012.03.027","article-title":"Efficacy of three candidate Rift Valley fever vaccines in sheep","volume":"30","author":"Kortekaas","year":"2012","journal-title":"Vaccine"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1089\/vbz.2014.1650","article-title":"A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep","volume":"14","author":"Faburay","year":"2014","journal-title":"Vector Borne Zoonotic Dis."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"27719","DOI":"10.1038\/srep27719","article-title":"A recombinant Rift Valley fever virus glycoprotein subunit vaccine confers full protection against Rift Valley fever challenge in sheep","volume":"6","author":"Faburay","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Wilson, W.C., Faburay, B., Trujillo, J.D., Ragan, I., Sunwoo, S.Y., Morozov, I., Shivanna, V., Balogh, A., Urbaniak, K., and McVey, D.S. (2021). Preliminary evaluation of a recombinant Rift Valley fever virus glycoprotein subunit vaccine providing full protection against heterologous virulent challenge in cattle. Vaccines, 9.","DOI":"10.3390\/vaccines9070748"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/01652176.2020.1714096","article-title":"Peste des petits ruminants in large ruminants, camels and unusual hosts","volume":"40","author":"Rahman","year":"2020","journal-title":"Vet. Q."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"935","DOI":"10.20506\/rst.9.4.532","article-title":"Peste des petits ruminants","volume":"9","author":"Lefevre","year":"1990","journal-title":"Rev. Sci. Tech."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3855\/jidc.15189","article-title":"Peste des petits ruminants virus antibodies in domestic large ruminants in Bangladesh","volume":"16","author":"Chowdhury","year":"2022","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_141","unstructured":"OIE, and World Organization for Animal Health (2013). Resolutions Adopted by the World Assembly Of delegates of the Oie during Its 81st General Session, OIE."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s00705-020-04732-1","article-title":"Peste des petits ruminants in Africa: A review of currently available molecular epidemiological data, 2020","volume":"165","author":"Dundon","year":"2020","journal-title":"Arch. Virol."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Couacy-Hymann, E., Berete, K., Odoom, T., Zerbo, L.H., Mathurin, K.Y., Kouakou, V.K., Doumbouya, M.I., Balde, A., Ababio, P.T., and Ouoba, L.B. (2023). The spread of peste des petits ruminants virus lineage IV in West Africa. Animals, 13.","DOI":"10.3390\/ani13071268"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/JVI.01471-18","article-title":"Comparison of the immunogenicities and cross-lineage efficacies of live attenuated peste des petits ruminants virus vaccines PPRV\/Nigeria\/75\/1 and PPRV\/Sungri\/96","volume":"92","author":"Hodgson","year":"2018","journal-title":"J. Virol."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Aziz, M.H., Shabbir, M.Z., Ali, M.M., Asif, Z., and Ijaz, M.U. (2022). Immunoinformatics approach for epitope mapping of immunogenic regions (N, F and H gene) of small ruminant morbillivirus and its comparative analysis with standard vaccinal strains for effective vaccine development. Vaccines, 10.","DOI":"10.3390\/vaccines10122179"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Selvaraj, M., Mahapatra, M., and Parida, S. (2021). Exchange of C-terminal variable sequences within morbillivirus nucleocapsid protein are tolerated: Development and evaluation of two marker (DIVA) vaccines (Sungri\/96 diva, Nigeria\/75\/1 DIVA) against PPR. Viruses, 13.","DOI":"10.3390\/v13112320"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"729879","DOI":"10.3389\/fvets.2021.729879","article-title":"A new look at vaccine strategies against PPRV focused on adenoviral candidates","volume":"8","author":"Rojas","year":"2021","journal-title":"Front. Vet. Sci."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jviromet.2013.07.031","article-title":"Immune responses in mice vaccinated with a suicidal DNA vaccine expressing the hemagglutinin glycoprotein from the peste des petits ruminants virus","volume":"193","author":"Wang","year":"2013","journal-title":"J. Virol. Methods"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jviromet.2015.09.001","article-title":"A suicidal DNA vaccine expressing the fusion protein of peste des petits ruminants virus induces both humoral and cell-mediated immune responses in mice","volume":"225","author":"Wang","year":"2015","journal-title":"J. Virol. Methods"},{"key":"ref_150","unstructured":"Norval, R.A.I., Perry, B.D., and Young, A. (1992). The Epidemiology of Theileriosis in Africa, Academic Press."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.onehlt.2016.07.002","article-title":"The control of east coast fever of cattle by live parasite vaccination: A science-to-impact narrative","volume":"2","author":"Perry","year":"2016","journal-title":"One Health"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/pim.12388","article-title":"Approaches to vaccination against Theileria parva and Theileria annulata","volume":"38","author":"Nene","year":"2016","journal-title":"Parasite Immunol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1016\/j.vaccine.2004.09.039","article-title":"Subunit vaccine based on the p67 major surface protein of Theileria parva sporozoites reduces severity of infection derived from field tick challenge","volume":"23","author":"Musoke","year":"2005","journal-title":"Vaccine"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.vaccine.2018.01.087","article-title":"Immune parameters to p67C antigen adjuvanted with ISA206VG correlate with protection against East Coast fever","volume":"36","author":"Lacasta","year":"2018","journal-title":"Vaccine"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"686","DOI":"10.4049\/jimmunol.2000442","article-title":"Synergistic effect of two nanotechnologies enhances the protective capacity of the Theileria parva sporozoite p67c antigen in cattle","volume":"206","author":"Lacasta","year":"2021","journal-title":"J. Immunol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1015840","DOI":"10.3389\/fimmu.2022.1015840","article-title":"Design and immunological evaluation of two-component protein nanoparticle vaccines for East Coast fever","volume":"13","author":"Lacasta","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.pt.2022.08.006","article-title":"East coast fever, a neglected tropical disease with an outdated vaccine approach?","volume":"38","author":"Kolakowski","year":"2022","journal-title":"Trends Parasitol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/mmi.13867","article-title":"Post-translational modifications as key regulators of apicomplexan biology: Insights from proteome-wide studies","volume":"107","author":"Yakubu","year":"2018","journal-title":"Mol. Microbiol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3389\/fvets.2020.00287","article-title":"Comparative transcriptomics of the bovine apicomplexan parasite Theileria parva developmental stages reveals massive gene expression variation and potential vaccine antigens","volume":"7","author":"Atchou","year":"2020","journal-title":"Front. Vet. Sci."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3389\/fvets.2017.00189","article-title":"Market impacts of reducing the prevalence of bovine respiratory disease in united states beef cattle feedlots","volume":"4","author":"Johnson","year":"2017","journal-title":"Front. Vet. Sci."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.prevetmed.2014.07.001","article-title":"Risk factors for bovine respiratory disease in australian feedlot cattle: Use of a causal diagram-informed approach to estimate effects of animal mixing and movements before feedlot entry","volume":"117","author":"Hay","year":"2014","journal-title":"Prev. Vet. Med."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.prevetmed.2016.01.025","article-title":"Effects of exposure to bovine viral diarrhoea virus 1 on risk of bovine respiratory disease in australian feedlot cattle","volume":"126","author":"Hay","year":"2016","journal-title":"Prev. Vet. Med."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.prevetmed.2016.01.024","article-title":"Associations between exposure to viruses and bovine respiratory disease in Australian feedlot cattle","volume":"127","author":"Hay","year":"2016","journal-title":"Prev. Vet. Med."},{"key":"ref_164","first-page":"33","article-title":"Bovine respiratory disease: Commercial vaccines currently available in Canada","volume":"41","author":"Bowland","year":"2000","journal-title":"Can. Vet. J."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2460\/javma.246.1.126","article-title":"Systematic review and meta-analysis of the effectiveness of commercially available vaccines against bovine herpesvirus, bovine viral diarrhea virus, bovine respiratory syncytial virus, and parainfluenza type 3 virus for mitigation of bovine respiratory disease complex in cattle","volume":"246","author":"Theurer","year":"2015","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Ambrose, R.K., Blakebrough-Hall, C., Gravel, J.L., Gonzalez, L.A., and Mahony, T.J. (2023). Characterisation of the upper respiratory tract virome of feedlot cattle and its association with bovine respiratory disease. Viruses, 15.","DOI":"10.3390\/v15020455"},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Esnault, G., Earley, B., Cormican, P., Waters, S.M., Lemon, K., Cosby, S.L., Lagan, P., Barry, T., Reddington, K., and McCabe, M.S. (2022). Assessment of rapid minion nanopore DNA virus meta-genomics using calves experimentally infected with bovine herpes virus-1. Viruses, 14.","DOI":"10.3390\/v14091859"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Brito, B.P., Frost, M.J., Anantanawat, K., Jaya, F., Batterham, T., Djordjevic, S.P., Chang, W.S., Holmes, E.C., Darling, A.E., and Kirkland, P.D. (2023). Expanding the range of the respiratory infectome in Australian feedlot cattle with and without respiratory disease using metatranscriptomics. Microbiome, 11.","DOI":"10.1186\/s40168-023-01591-1"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1071\/AN22451","article-title":"Skim-nanopore sequencing for routine genomic evaluation and bacterial pathogen detection in cattle","volume":"63","author":"Lamb","year":"2023","journal-title":"Anim. Prod. Sci."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"eadh1655","DOI":"10.1126\/sciadv.adh1655","article-title":"Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection","volume":"9","author":"Meyer","year":"2023","journal-title":"Sci. Adv."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"eadf9556","DOI":"10.1126\/scitranslmed.adf9556","article-title":"A protein-free vaccine stimulates innate immunity and protects against nosocomial pathogens","volume":"15","author":"Yan","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/avj.13156","article-title":"The innate immune stimulant Amplimune\u00ae is safe to administer to young feedlot cattle","volume":"100","author":"Alexander","year":"2022","journal-title":"Aust. Vet. J."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1515\/acve-2017-0019","article-title":"Mycobacterium cell wall fraction immunostimulant (AMPLIMUNE\u2122) efficacy in the reduction of the severity of ETEC induced diarrhea in neonatal calves","volume":"67","author":"Romanowski","year":"2017","journal-title":"Acta Vet."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.pt.2014.04.009","article-title":"Chasing helminths and their economic impact on farmed ruminants","volume":"30","author":"Charlier","year":"2014","journal-title":"Trends Parasitol."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Adduci, I., Sajovitz, F., Hinney, B., Lichtmannsperger, K., Joachim, A., Wittek, T., and Yan, S. (2022). Haemonchosis in sheep and goats, control strategies and development of vaccines against Haemonchus contortus. Animals, 12.","DOI":"10.3390\/ani12182339"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/avj.12250","article-title":"Anthelmintic resistance in ovine gastrointestinal nematodes in inland southern Queensland","volume":"92","author":"Ehrlich","year":"2014","journal-title":"Aust. Vet. J."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0020-7519(03)00167-X","article-title":"The nature and prospects for gut membrane proteins as vaccine candidates for Haemonchus contortus and other ruminant trichostrongyloids","volume":"33","author":"Knox","year":"2003","journal-title":"Int. J. Parasitol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF01200452","article-title":"Vaccination against Boophilus microplus: Localization of antigens on tick gut cells and their interaction with the host immune system","volume":"7","author":"Kemp","year":"1989","journal-title":"Exp. Appl. Acarol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"9657","DOI":"10.1073\/pnas.86.24.9657","article-title":"Cloning and expression of a protective antigen from the cattle tick Boophilus microplus","volume":"86","author":"Rand","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.4049\/jimmunol.143.4.1346","article-title":"Immunologic control of a parasitic arthropod. Identification of a protective antigen from Boophilus microplus","volume":"143","author":"Willadsen","year":"1989","journal-title":"J. Immunol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1297-9716-44-111","article-title":"Novel expression of Haemonchus contortus vaccine candidate aminopeptidase h11 using the free-living nematode Caenorhabditis elegans","volume":"44","author":"Roberts","year":"2013","journal-title":"Vet. Res."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"30561","DOI":"10.1074\/jbc.271.48.30561","article-title":"Haemonchus contortus glycoproteins contain N-linked oligosaccharides with novel highly fucosylated core structures","volume":"271","author":"Haslam","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1034820","DOI":"10.3389\/fimmu.2022.1034820","article-title":"H11-induced immunoprotection is predominantly linked to N-glycan moieties during Haemonchus contortus infection","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1365-3024.2000.00303.x","article-title":"Evaluation of immunization with gut membrane glycoproteins of ostertagia ostertagi against homologous challenge in calves and against Haemonchus contortus in sheep","volume":"22","author":"Smith","year":"2000","journal-title":"Parasite Immunol."},{"key":"ref_185","unstructured":"(2023, August 03). Barbervax\u2014Vaccination Schedle. Available online: https:\/\/barbervax.com\/how-to-use\/."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1080\/14760584.2020.1857736","article-title":"B cell targeting by molecular adjuvants for enhanced immunogenicity","volume":"19","author":"Sicard","year":"2020","journal-title":"Expert Rev. Vaccines"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"e1386","DOI":"10.1016\/S2214-109X(18)30346-2","article-title":"Estimating the cost of vaccine development against epidemic infectious diseases: A cost minimisation study","volume":"6","author":"Gouglas","year":"2018","journal-title":"Lancet Glob. Health"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1016\/j.vaccine.2017.06.003","article-title":"The complexity and cost of vaccine manufacturing\u2014An overview","volume":"35","author":"Plotkin","year":"2017","journal-title":"Vaccine"},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Pronker, E.S., Weenen, T.C., Commandeur, H., Claassen, E.H., and Osterhaus, A.D. (2013). Risk in vaccine research and development quantified. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0057755"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"e073747","DOI":"10.1136\/bmj-2022-073747","article-title":"Us public investment in development of mrna COVID-19 vaccines: Retrospective cohort study","volume":"380","author":"Lalani","year":"2023","journal-title":"BMJ"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics-developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Uddin, M.N., and Roni, M.A. (2021). Challenges of storage and stability of mRNA-based COVID-19 vaccines. Vaccines, 9.","DOI":"10.3390\/vaccines9091033"},{"key":"ref_193","unstructured":"(2023). Animal Health and Sustainability: A Global Data Analysis, Health for Animals\u2014Global Animal Health Association."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/2\/152\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:52:27Z","timestamp":1760104347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/2\/152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,31]]},"references-count":193,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["vaccines12020152"],"URL":"https:\/\/doi.org\/10.3390\/vaccines12020152","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,31]]}}}